TGE Value Creative Solutions Corp. (BEBE)
10.07
+0.01
(+0.10%)
USD |
NYSE |
Nov 06, 16:00
10.07
0.00 (0.00%)
After-Hours: 20:00
TGE Value Creative Solutions Enterprise Value : 200.96M for Nov. 6, 2026
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| November 06, 2026 | 200.96M |
| November 05, 2026 | 200.76M |
| November 04, 2026 | 200.76M |
| November 03, 2026 | 200.56M |
| November 02, 2026 | 200.56M |
| October 30, 2026 | 200.56M |
| October 29, 2026 | 200.56M |
| October 28, 2026 | 201.56M |
| October 27, 2026 | 201.56M |
| October 26, 2026 | 201.56M |
| October 23, 2026 | 201.56M |
| October 22, 2026 | 201.56M |
| October 21, 2026 | 201.56M |
| October 20, 2026 | 201.56M |
| October 19, 2026 | 201.56M |
| October 16, 2026 | 201.56M |
| October 15, 2026 | 201.56M |
| October 14, 2026 | 200.76M |
| October 13, 2026 | 200.56M |
| October 12, 2026 | 200.56M |
| October 09, 2026 | 200.56M |
| October 08, 2026 | 200.56M |
| October 07, 2026 | 200.56M |
| October 06, 2026 | 200.56M |
| October 05, 2026 | 200.56M |
| Date | Value |
|---|---|
| October 02, 2026 | 200.36M |
| October 01, 2026 | 200.36M |
| September 30, 2026 | 200.36M |
| September 29, 2026 | 200.36M |
| September 28, 2026 | 200.36M |
| September 25, 2026 | 200.36M |
| September 24, 2026 | 200.36M |
| September 23, 2026 | 200.36M |
| September 22, 2026 | 200.36M |
| September 21, 2026 | 200.36M |
| September 18, 2026 | 200.36M |
| September 17, 2026 | 200.36M |
| September 16, 2026 | 200.36M |
| September 15, 2026 | 200.36M |
| September 14, 2026 | 200.56M |
| September 11, 2026 | 200.16M |
| September 10, 2026 | 199.16M |
| September 09, 2026 | 199.16M |
| September 08, 2026 | 199.16M |
| September 04, 2026 | 199.16M |
| September 03, 2026 | 199.16M |
| September 02, 2026 | 199.16M |
| September 01, 2026 | 199.16M |
| August 31, 2026 | 199.16M |
| August 28, 2026 | 199.16M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Enterprise Value Benchmarks
| Sanofi | 123.44B |
| DBV Technologies SA | 513.19M |
| Cellectis SA | 45.18M |
| Innate Pharma SA | -- |
| Inventiva SA | 846.48M |
Enterprise Value Related Metrics
| Net Income (Quarterly) | 1.362M |
| Total Expenses (Quarterly) | -1.362M |
| EPS Diluted (Quarterly) | 0.0681 |
| Earnings Yield | 1.41% |
| Normalized Earnings Yield | 1.410 |